Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities. Participate in obesity education and networking activities, as well as leadership and program development opportunities, including webinars, event meetups, collaborative projects, and more!
Upcoming Webinar (with Bone & Mineral SIG): Skeletal Physiology, Weight Wellness, and Optimizing The Musculoskeletal Healthspan
Date: April 21, 2026 Time: 11:00 AM – 12:30 PM ET
Moderators:
Jami Josefson, MD, MS
Associate Professor of Pediatrics - Endocrinology
Feinberg School of Medicine
Northwestern University
M. Furkan Burak, MD
Instructor in Medicine - Endocrinology, Diabetes and Hypertension
Mass General Brigham
Harvard Medical School
Dwight A. Towler, MD, PhD
Professor of Medicine - Diabetes Endocrinology and Metabolism
Vanderbilt University Medical Center
Vanderbilt Health
Speakers:
Clifford J. Rosen, MD
Professor and Director, Tufts Clinical and Translational Science Institute
Maine Medical Center Research Institute
Tufts University School of Medicine Topic: GLP1 Endocrine Pharmacology, Marrow Physiology and Skeletal Health
Sowmya Krishnan, MD
Professor of Pediatrics - Endocrinology
Children’s Medical Center of Dallas
UT Southwestern Medical Center Topic: Obesity Management in Adolescents and Young Adults: Strategies and Unmet Needs Relevant To Optimizing the Skeletal Healthspan
Elaine Yu, MD, MMSC
Associate Professor of Medicine - Endocrinology
Mass General Brigham / HSM
Harvard University Topic: Balancing Weight Wellness and Musculoskeletal Fraily in Aging Patients using GLP1/GIP Agonists
Description:
This is a collaborative webinar on obesity management, weight wellness, and musculoskeletal health. In the era of GLP1 agonist - based therapies used to successfully achieve weight wellness, a better understanding of these impact skeletal physiology across the healthspan is needed. The complex pharmacology of GLP1/GIP agents on marrow cell fate and phenotype as relevant to skeletal physiology and obesity medicine is presented by Dr. Rosen. The gaps and needs in pediatric/adolescent weight wellness as relates to young adult bone health will be addressed by Dr. Krishnan. Dr. Yu will reflect upon the integrated goals of care for T2D, obesity and weight wellness management vis-a-vis musculoskeletal frailty risk in our aging population. After the 3 individual presentations, there would be a ca. 30 minute online panel discussion of the unmet scientific/clinical needs and future directions – with a post-webinar strategy discussion for getting this topic on the ENDO 2027 schedule as a symposium.
Learning Objectives:
Described the impact of GLP1 receptor agonists on marrow mesenchymal cell lineage allocation and osteoblast-osteoclast interactions determine bone mass and strength
Understand the role of achieving peak bone mass in young adulthood on skeletal strength across the lifespan, and impacts of well wellness management on bone mass accrual in the maturing skeleton.
Describe the integrated goals of care for managing T2D, obesity and weight wellness while mitigating musculoskeletal frailty and fracture risk in our aging patients.
Please note: you must be a member of the SIG to view these webinar recordings.
Past Obesity SIG Webinars
Joint EDC/Obesity SIG Webinar: Reprogrammed by Chemicals: The Epigenetic Link Between Environmental Exposure and Obesity
Date: February 6, 2026
Moderators:
Aldo E. Calogero, MD, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Rossella Cannarella, MD, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Speakers:
Furkan M Burak, MD, PhD, Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health; Division of Endocrinology, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Giovanna Muscogiuri, MD, PhD, Department of Clinical Medicine and Surgery, Italian Center for the Care and Well-being of Patients with Obesity (C.I.B.O), University of Naples Federico II, Naples, Italy, Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ, USA.
Andrea Crafa, MD, PhD, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy
Oliver J. Rando, MD, PhD, Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Description:
This webinar will explore the emerging role of environmental and epigenetic factors in the development and transgenerational transmission of obesity. Bringing together leading experts in endocrinology, metabolism, and reproductive epigenetics, the event will examine how endocrine-disrupting chemicals and lifestyle-related factors interact with adipose tissue biology and germ cell epigenetics. Particular attention will be given to the impact of environmental exposures and paternal obesity on sperm epigenetic programming and long-term metabolic health across generations. Through an integrated and multidisciplinary perspective, the webinar aims to provide novel insights into the complex mechanisms linking environment, epigenetics, and obesity.
Objectives:
To understand the global burden of obesity and the multifactorial mechanisms underlying its development, including genetic, environmental, and epigenetic contributors.
To examine the obesogenic effects of endocrine-disrupting chemicals on adipocyte biology and metabolic regulation.
To explore how environmental exposures and paternal obesity influence sperm epigenetics and contribute to the transgenerational transmission of obesity risk.
Friday, May 30, 2025 Speaker:
Marcelo Correia MD, MSc, PhD, DABOM; University of Iowa, Division of Endocrinology; VAMC
Description:
To give an overview of diets and dietary strategies to manage obesity, particularly in the setting of potent anti-obesity medicines
Learning Objectives:
Dietary strategies to manage obesity
Discuss different types of diet recommended by professional societies
Discuss dietary strategies for muscle mass preservation during treatment with incretin-based anti-obesity medicines
March 4, 2025
Speaker:
Mehmet Furkan Burak, MD, co-chair of Obesity SIG, Brigham and Women’s Hospital, Harvard Medical School
Description:
In this interactive webinar, Dr. Burak will review the paradigm shift in obesity treatment, review what changed in treatment landscape, and where it's going with pipeline data review.
Learning Objectives:
Objective 1: Understand the current pharmacological options of obesity treatment
Objective 2: Understand the biology of energy regulation and weight management
Objective 3: Review the current data for major obesity treatments in clinical trials.
Collaborate with peers on clinical care and research related to obesity. The SIG will discuss topics such as the pharmacoeconomics of obesity, funding opportunities, how NuSH-based AOMs are changing obesity treatment, and engaging with multidisciplinary subspecialties to bridge care gaps in obesity-related comorbidities. Participate in obesity education and networking activities, as well as leadership and program development opportunities, including webinars, event meetups, collaborative projects, and more! 
